Pharmacokinetics of Recombinant Human Granulocyte-Macrophage Colony-Stimulating Factor in Children after Intravenous and Subcutaneous Administration

This publication has 15 references indexed in Scilit:

• Comparative pharmacokinetics of single‐dose administration of mammalian and bacterially‐derived recombinant human granulocyte‐macrophage colony‐stimulating factor
  European Journal of Haematology, 1993
• Granulocyte-macrophage colony-stimulating factor: Preliminary observations on the influences of dose, schedule, and route of administration in patients receiving cyclophosphamide and carboplatin
  Cancer, 1992
• Disposition of recombinant human granulocyte-macrophage colony- stimulating factor in patients receiving high-dose chemotherapy and autologous bone marrow support
  Blood, 1992
• Granulocyte Colony-Stimulating Factor and Granulocyte-Macrophage Colony-Stimulating Factor
  New England Journal of Medicine, 1992
• Granulocyte Colony-Stimulating Factor and Granulocyte-Macrophage Colony-Stimulating Factor
  New England Journal of Medicine, 1992
• The dissociation of GM‐CSF efficacy from toxicity according to route of administration: a pharmacodynamic study
  British Journal of Haematology, 1992
• Potential Uses of Recombinant Human Granulocyte-Macrophage Colony-Stimulating Factor in Children
  Journal of Pediatric Hematology/Oncology, 1991
• M‐07e human leukemic factor‐dependent cell line provides a rapid and sensitive bioassay for the human cytokines GM‐CSF and IL‐3
  Journal of Cellular Physiology, 1990
• The effects of dose and route of the administration on the pharmacokinetics of granulocyte-macrophage colony-stimulating factor
  European Journal of Cancer and Clinical Oncology, 1990
• Hematopoietic responses in patients with advanced malignancy treated with recombinant human granulocyte-macrophage colony-stimulating factor.
  Journal of Clinical Oncology, 1989